Journal of Clinical Investigation Archive
-
March 21, 2013
Breast cancer study explores therapy to slow recurrence
Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. -
February 6, 2013
Linking oxygen, iron and red blood cells
The HIF oxygen-sensing pathway and its responses to low oxygen may be targeted for treatments of anemia and disorders of iron balance. -
January 31, 2013
Do-it-yourself repair in the kidney
The kidney can mediate its own repair through proliferation of resident immune system cells. -
August 9, 2012
New therapeutic target for cold, flu viruses identified
Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells. -
October 7, 2011
Heart protein may be target for colon cancer therapies
A protein critical in heart development may also play a part in colon cancer progression.